APW
UTHR icon

Aventura Private Wealth’s United Therapeutics UTHR Stock Holding History

Aventura Private Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3K Hold
19
– – ﹤0.01% 588
2026
Q1 		$11.3K Hold
19
– – ﹤0.01% 529
2025
Q4 		$9.26K Hold
19
– – ﹤0.01% 515
2025
Q3 		$7.96K Hold
19
– – ﹤0.01% 524
2025
Q2 		$5.46K Hold
19
– – ﹤0.01% 536
2025
Q1 		$5.86K Hold
19
– – ﹤0.01% 514
2024
Q4 		$6.7K Buy
+19
New +$6.98K ﹤0.01% 484

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Aventura Private Wealth's UTHR Position: Q2 2026 in Review

Aventura Private Wealth held its United Therapeutics (UTHR) position steady in Q2 2026 at 19 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Aventura Private Wealth first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $11.3K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Aventura Private Wealth held 19 shares of United Therapeutics worth $10.3K as of Q2 2026.
  • Aventura Private Wealth left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Aventura Private Wealth's portfolio in Q2 2026, its #588 holding.
  • Aventura Private Wealth first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Aventura Private Wealth's United Therapeutics position peaked at $11.3K in Q1 2026.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.